Category: Pulmonary Diseases and Critical Care Medicine
Scientists Demonstrate Promising New Approach for Treating Cystic Fibrosis
Scientists led by Silvia Kreda, PhD, associate professor in the division of pulmonary diseases and critical care medicine, and Rudolph Juliano, PhD, Boshamer Distinguished Professor Emeritus in pharmacology, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such as COPD and asthma. The scientists led a collaboration of … Read more
UNC Health Reaches Milestone of Zero COVID Patients For 36-Hour Span
For the first time in more than a year, UNC Health reported zero patients in the COVID unit at UNC Medical Center. It was just a 36-hour span this month but it was momentous considering what the unit looked like at the start of the year. Ashley Henderson, MD, associate professor of medicine in the division of pulmonary diseases and critical care medicine, was interviewed in the W … Read more
Patel, Jain Join OAE To Provide Student Support Across the State
The UNC Office of Academic Excellence is a group of faculty and staff who support students academically through the pre-clinical and clinical years, providing coaching, clinical skills training, and test-taking guidance. The OAE recently announced new faculty members who will join the OAE to provide student support across the state. Kunal Patel, MD, PhD, from the division of pulm … Read more
Department of Medicine Grants & Funding: May 1 – May 31, 2021
Division of Infectious Diseases Lisa Hightow-Weidman, MD, PhD, received an NIMHD grant award for “A multidimensional digital approach to address vaccine hesitancy and increase COVID-19 vaccine uptake among African American young adults in the South.” Division of Pulmonary and Critical Care Medicine Michael Knowles, MD, received a grant award from the Cystic Fibrosis Foundation fo … Read more
Combating Vaccine Hesitancy Among Gen Z As COVID Cases, Hospital Admissions Tick Up
Young adults between the ages of 18 and 24 account for a growing share of new COVID-19 cases and patients in hospitals — even as surveys show that group with a higher rate of hesitancy for the vaccine. “Young people need to understand that even if they get COVID, they can be symptomatic for quite some time — it can change their life, at least in the near term, even if it doesn’t … Read more
COVID-19 Reflections One Year Later
One year has passed since Governor Cooper declared a state of emergency for North Carolina due to the COVID-19 pandemic, and hospitals and health systems across the state had to pivot to take care of their patients. Jason Mock, MD, PhD, assistant professor of medicine in the division of pulmonary diseases and critical care medicine, reflected on the past year in an ABC-11 news re … Read more
Antiviral Pill Could Alter the Fight Against COVID
The International Business Times reports on the drug molnupiravir, which has shown positive results in preliminary studies by significantly reducing infection of the virus in patients after five days of treatment. William Fischer, MD, associate professor of medicine in the division of pulmonary diseases and critical care medicine, and lead investigator of the study at UNC, said t … Read more
-
Can COVID-19 Be Treated With a Pill?
William Fischer, MD, associate professor of medicine in the division of pulmonary and critical care medicine, who led UNC trials to determine if Molnupiravir could be a possible treatment for COVID-19, was quoted in a CBS-17 News report about its potential to change the way COVID-19 is treated. “The secondary objective findings in this study, of a quicker decrease in infectious v … Read more
New Lung Cancer Screening Recommendation Expands Access But May Not Address Inequities
Calling the U.S. Preventive Services Task Force’s newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, researchers say future changes should address equity and implementation issues. In an editorial published in JAMA, M. Patricia Rivera, MD, professor of medicine in the division of pulmona … Read more
-
Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic
The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine’s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801. Merck and Ridgeback Biotherapeutics announced preliminary results from R … Read more
Al-Qadi Receives CHEST Research Award
Mazen O. Al-Qadi, assistant professor in pulmonary and critical care medicine has received the Alfred Soffer Research Award for “Respiratory variation in right atrial pressure predicts right ventricular dysfunction in patients with precapillary pulmonary hypertension.” This award is named in honor of Dr. Alfred Soffer, Master Fellow of the College, Editor-in-Chief of the journal … Read more
Knowles Comments on Durham-Based Startup and Potential New COVID-19 Treatment
An NPR Blue Ridge Radio reports that a Durham-based life sciences company received promising test results on a new medical device that could become an in-home treatment for the coronavirus. Michael Knowles, MD, the Michael E. Hatcher Distinguished Professor of Medicine in the division of pulmonary diseases and critical care medicines, commented in a statement distributed by EmitB … Read more